nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—Medrysone—Prednisolone—hematologic cancer	0.0909	0.422	CrCrCtD
Finasteride—Progesterone—Prednisolone—hematologic cancer	0.0666	0.309	CrCrCtD
Finasteride—Testosterone—Prednisolone—hematologic cancer	0.0578	0.268	CrCrCtD
Finasteride—CYP3A7—Ifosfamide—hematologic cancer	0.0274	0.0486	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0274	0.0486	CbGbCtD
Finasteride—CYP3A7—Imatinib—hematologic cancer	0.0261	0.0464	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0261	0.0464	CbGbCtD
Finasteride—CYP3A5—Daunorubicin—hematologic cancer	0.0256	0.0455	CbGbCtD
Finasteride—CYP3A5—Thalidomide—hematologic cancer	0.0233	0.0414	CbGbCtD
Finasteride—CYP3A5—Teniposide—hematologic cancer	0.0222	0.0395	CbGbCtD
Finasteride—CYP3A5—Ifosfamide—hematologic cancer	0.0205	0.0365	CbGbCtD
Finasteride—CYP3A5—Imatinib—hematologic cancer	0.0196	0.0348	CbGbCtD
Finasteride—CYP3A4—Bexarotene—hematologic cancer	0.017	0.0303	CbGbCtD
Finasteride—CYP3A7—Irinotecan—hematologic cancer	0.0163	0.029	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0163	0.029	CbGbCtD
Finasteride—CYP3A4—Lomustine—hematologic cancer	0.0158	0.0281	CbGbCtD
Finasteride—CYP3A4—Busulfan—hematologic cancer	0.0158	0.0281	CbGbCtD
Finasteride—CYP3A5—Dasatinib—hematologic cancer	0.0157	0.028	CbGbCtD
Finasteride—CYP3A7—Vincristine—hematologic cancer	0.0143	0.0254	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0143	0.0254	CbGbCtD
Finasteride—CYP3A4—Thiotepa—hematologic cancer	0.0141	0.0251	CbGbCtD
Finasteride—CYP3A5—Irinotecan—hematologic cancer	0.0122	0.0218	CbGbCtD
Finasteride—CYP3A4—Methoxsalen—hematologic cancer	0.011	0.0195	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.0108	0.0191	CbGbCtD
Finasteride—CYP3A7—Dexamethasone—hematologic cancer	0.0108	0.0191	CbGbCtD
Finasteride—CYP3A5—Vincristine—hematologic cancer	0.0107	0.019	CbGbCtD
Finasteride—CYP3A4—Bortezomib—hematologic cancer	0.0104	0.0185	CbGbCtD
Finasteride—CYP3A4—Daunorubicin—hematologic cancer	0.00998	0.0177	CbGbCtD
Finasteride—CYP3A5—Etoposide—hematologic cancer	0.00981	0.0174	CbGbCtD
Finasteride—CYP3A4—Cytarabine—hematologic cancer	0.00881	0.0156	CbGbCtD
Finasteride—CYP3A4—Teniposide—hematologic cancer	0.00867	0.0154	CbGbCtD
Finasteride—CYP3A5—Dexamethasone—hematologic cancer	0.00807	0.0143	CbGbCtD
Finasteride—CYP3A4—Ifosfamide—hematologic cancer	0.008	0.0142	CbGbCtD
Finasteride—CYP3A4—Imatinib—hematologic cancer	0.00765	0.0136	CbGbCtD
Finasteride—CYP3A4—Ruxolitinib—hematologic cancer	0.0072	0.0128	CbGbCtD
Finasteride—CYP3A4—Nilotinib—hematologic cancer	0.00695	0.0123	CbGbCtD
Finasteride—CYP3A4—Vinorelbine—hematologic cancer	0.00689	0.0122	CbGbCtD
Finasteride—CYP3A4—Triamcinolone—hematologic cancer	0.0063	0.0112	CbGbCtD
Finasteride—CYP3A4—Dasatinib—hematologic cancer	0.00614	0.0109	CbGbCtD
Finasteride—CYP3A4—Mitoxantrone—hematologic cancer	0.00607	0.0108	CbGbCtD
Finasteride—CYP3A4—Betamethasone—hematologic cancer	0.00541	0.00961	CbGbCtD
Finasteride—CYP3A4—Prednisolone—hematologic cancer	0.00533	0.00948	CbGbCtD
Finasteride—CYP3A4—Prednisone—hematologic cancer	0.00504	0.00895	CbGbCtD
Finasteride—CYP3A4—Irinotecan—hematologic cancer	0.00478	0.00849	CbGbCtD
Finasteride—CYP3A4—Vinblastine—hematologic cancer	0.00425	0.00754	CbGbCtD
Finasteride—CYP3A4—Vincristine—hematologic cancer	0.00417	0.00742	CbGbCtD
Finasteride—CYP3A4—Etoposide—hematologic cancer	0.00383	0.0068	CbGbCtD
Finasteride—CYP3A4—Dexamethasone—hematologic cancer	0.00315	0.00559	CbGbCtD
Finasteride—CYP3A4—Doxorubicin—hematologic cancer	0.00261	0.00464	CbGbCtD
Finasteride—Drostanolone—AR—hematologic cancer	0.000751	0.195	CrCbGaD
Finasteride—Testosterone Propionate—UGT1A1—hematologic cancer	0.000641	0.166	CrCbGaD
Finasteride—Medrysone—NR3C1—hematologic cancer	0.000479	0.124	CrCbGaD
Finasteride—Testosterone Propionate—AR—hematologic cancer	0.000458	0.119	CrCbGaD
Finasteride—Progesterone—SLC22A1—hematologic cancer	0.000237	0.0613	CrCbGaD
Finasteride—Testosterone—SLC22A1—hematologic cancer	0.000224	0.0579	CrCbGaD
Finasteride—Progesterone—AR—hematologic cancer	0.00021	0.0545	CrCbGaD
Finasteride—Testosterone—AR—hematologic cancer	0.000199	0.0515	CrCbGaD
Finasteride—Progesterone—ESR1—hematologic cancer	0.000162	0.042	CrCbGaD
Finasteride—Testosterone—ABCG2—hematologic cancer	0.000156	0.0405	CrCbGaD
Finasteride—Progesterone—NR3C1—hematologic cancer	0.000143	0.0369	CrCbGaD
Finasteride—Headache—Cladribine—hematologic cancer	0.000138	0.000757	CcSEcCtD
Finasteride—Dyspnoea—Alitretinoin—hematologic cancer	0.000137	0.000755	CcSEcCtD
Finasteride—Somnolence—Alitretinoin—hematologic cancer	0.000137	0.000753	CcSEcCtD
Finasteride—Dyspnoea—Ifosfamide—hematologic cancer	0.000136	0.000746	CcSEcCtD
Finasteride—Somnolence—Ifosfamide—hematologic cancer	0.000135	0.000744	CcSEcCtD
Finasteride—Hypotension—Mitoxantrone—hematologic cancer	0.000135	0.000743	CcSEcCtD
Finasteride—Hypotension—Irinotecan—hematologic cancer	0.000135	0.000743	CcSEcCtD
Finasteride—Urticaria—Thiotepa—hematologic cancer	0.000133	0.000731	CcSEcCtD
Finasteride—Pain—Carmustine—hematologic cancer	0.000133	0.000731	CcSEcCtD
Finasteride—Angioedema—Prednisolone—hematologic cancer	0.000133	0.00073	CcSEcCtD
Finasteride—Breast disorder—Methotrexate—hematologic cancer	0.000132	0.000728	CcSEcCtD
Finasteride—Hypersensitivity—Bortezomib—hematologic cancer	0.000132	0.000727	CcSEcCtD
Finasteride—Headache—Vinblastine—hematologic cancer	0.000132	0.000726	CcSEcCtD
Finasteride—Pain—Alitretinoin—hematologic cancer	0.000132	0.000724	CcSEcCtD
Finasteride—Hypotension—Gemcitabine—hematologic cancer	0.000132	0.000723	CcSEcCtD
Finasteride—Hypersensitivity—Bleomycin—hematologic cancer	0.000131	0.000722	CcSEcCtD
Finasteride—Infection—Cisplatin—hematologic cancer	0.00013	0.000717	CcSEcCtD
Finasteride—Pain—Ifosfamide—hematologic cancer	0.00013	0.000716	CcSEcCtD
Finasteride—Hypersensitivity—Vinorelbine—hematologic cancer	0.000129	0.00071	CcSEcCtD
Finasteride—Dizziness—Lenalidomide—hematologic cancer	0.000129	0.000709	CcSEcCtD
Finasteride—Dyspnoea—Irinotecan—hematologic cancer	0.000129	0.000708	CcSEcCtD
Finasteride—Dyspnoea—Mitoxantrone—hematologic cancer	0.000129	0.000708	CcSEcCtD
Finasteride—Asthenia—Bortezomib—hematologic cancer	0.000129	0.000708	CcSEcCtD
Finasteride—Urticaria—Thalidomide—hematologic cancer	0.000129	0.000707	CcSEcCtD
Finasteride—Somnolence—Irinotecan—hematologic cancer	0.000129	0.000706	CcSEcCtD
Finasteride—Somnolence—Mitoxantrone—hematologic cancer	0.000129	0.000706	CcSEcCtD
Finasteride—Asthenia—Bleomycin—hematologic cancer	0.000128	0.000703	CcSEcCtD
Finasteride—Dizziness—Hydroxyurea—hematologic cancer	0.000127	0.000699	CcSEcCtD
Finasteride—Pruritus—Bortezomib—hematologic cancer	0.000127	0.000698	CcSEcCtD
Finasteride—Pain—Vincristine—hematologic cancer	0.000127	0.000698	CcSEcCtD
Finasteride—Rash—Melphalan—hematologic cancer	0.000127	0.000695	CcSEcCtD
Finasteride—Dermatitis—Melphalan—hematologic cancer	0.000126	0.000695	CcSEcCtD
Finasteride—Pruritus—Bleomycin—hematologic cancer	0.000126	0.000693	CcSEcCtD
Finasteride—Asthenia—Vinorelbine—hematologic cancer	0.000126	0.000691	CcSEcCtD
Finasteride—Dyspnoea—Gemcitabine—hematologic cancer	0.000126	0.00069	CcSEcCtD
Finasteride—Orthostatic hypotension—Epirubicin—hematologic cancer	0.000125	0.000689	CcSEcCtD
Finasteride—Somnolence—Gemcitabine—hematologic cancer	0.000125	0.000688	CcSEcCtD
Finasteride—Pruritus—Vinorelbine—hematologic cancer	0.000124	0.000682	CcSEcCtD
Finasteride—Breast disorder—Epirubicin—hematologic cancer	0.000124	0.000681	CcSEcCtD
Finasteride—Pain—Irinotecan—hematologic cancer	0.000124	0.00068	CcSEcCtD
Finasteride—Pain—Mitoxantrone—hematologic cancer	0.000124	0.00068	CcSEcCtD
Finasteride—Hypersensitivity—Thiotepa—hematologic cancer	0.000123	0.000678	CcSEcCtD
Finasteride—Rash—Lenalidomide—hematologic cancer	0.000123	0.000676	CcSEcCtD
Finasteride—Dermatitis—Lenalidomide—hematologic cancer	0.000123	0.000676	CcSEcCtD
Finasteride—Hypotension—Cisplatin—hematologic cancer	0.000123	0.000674	CcSEcCtD
Finasteride—Urticaria—Alitretinoin—hematologic cancer	0.000122	0.000673	CcSEcCtD
Finasteride—Headache—Lenalidomide—hematologic cancer	0.000122	0.000672	CcSEcCtD
Finasteride—Angioedema—Triamcinolone—hematologic cancer	0.000122	0.000671	CcSEcCtD
Finasteride—Rash—Hydroxyurea—hematologic cancer	0.000121	0.000667	CcSEcCtD
Finasteride—Dermatitis—Hydroxyurea—hematologic cancer	0.000121	0.000666	CcSEcCtD
Finasteride—Urticaria—Ifosfamide—hematologic cancer	0.000121	0.000665	CcSEcCtD
Finasteride—Headache—Hydroxyurea—hematologic cancer	0.000121	0.000662	CcSEcCtD
Finasteride—Pain—Gemcitabine—hematologic cancer	0.00012	0.000662	CcSEcCtD
Finasteride—Asthenia—Thiotepa—hematologic cancer	0.00012	0.00066	CcSEcCtD
Finasteride—Infection—Etoposide—hematologic cancer	0.00012	0.000657	CcSEcCtD
Finasteride—Hypersensitivity—Thalidomide—hematologic cancer	0.000119	0.000656	CcSEcCtD
Finasteride—Dizziness—Bortezomib—hematologic cancer	0.000119	0.000653	CcSEcCtD
Finasteride—Influenza—Epirubicin—hematologic cancer	0.000119	0.000652	CcSEcCtD
Finasteride—Pruritus—Thiotepa—hematologic cancer	0.000118	0.000651	CcSEcCtD
Finasteride—Dyspnoea—Cisplatin—hematologic cancer	0.000117	0.000643	CcSEcCtD
Finasteride—Erectile dysfunction—Methotrexate—hematologic cancer	0.000117	0.000641	CcSEcCtD
Finasteride—Asthenia—Thalidomide—hematologic cancer	0.000116	0.000639	CcSEcCtD
Finasteride—Dizziness—Vinorelbine—hematologic cancer	0.000116	0.000637	CcSEcCtD
Finasteride—Orthostatic hypotension—Doxorubicin—hematologic cancer	0.000116	0.000637	CcSEcCtD
Finasteride—Urticaria—Mitoxantrone—hematologic cancer	0.000115	0.000631	CcSEcCtD
Finasteride—Breast disorder—Doxorubicin—hematologic cancer	0.000115	0.00063	CcSEcCtD
Finasteride—Hypersensitivity—Carmustine—hematologic cancer	0.000115	0.00063	CcSEcCtD
Finasteride—Pruritus—Thalidomide—hematologic cancer	0.000115	0.00063	CcSEcCtD
Finasteride—Bronchitis—Epirubicin—hematologic cancer	0.000114	0.000627	CcSEcCtD
Finasteride—Hypersensitivity—Alitretinoin—hematologic cancer	0.000114	0.000624	CcSEcCtD
Finasteride—Rash—Bortezomib—hematologic cancer	0.000113	0.000622	CcSEcCtD
Finasteride—Dermatitis—Bortezomib—hematologic cancer	0.000113	0.000622	CcSEcCtD
Finasteride—Headache—Bortezomib—hematologic cancer	0.000113	0.000618	CcSEcCtD
Finasteride—Hypotension—Etoposide—hematologic cancer	0.000112	0.000618	CcSEcCtD
Finasteride—Rash—Bleomycin—hematologic cancer	0.000112	0.000617	CcSEcCtD
Finasteride—Pain—Cisplatin—hematologic cancer	0.000112	0.000617	CcSEcCtD
Finasteride—Dermatitis—Bleomycin—hematologic cancer	0.000112	0.000617	CcSEcCtD
Finasteride—Hypersensitivity—Ifosfamide—hematologic cancer	0.000112	0.000617	CcSEcCtD
Finasteride—Asthenia—Carmustine—hematologic cancer	0.000112	0.000613	CcSEcCtD
Finasteride—Angioedema—Betamethasone—hematologic cancer	0.000111	0.000609	CcSEcCtD
Finasteride—Angioedema—Dexamethasone—hematologic cancer	0.000111	0.000609	CcSEcCtD
Finasteride—Dizziness—Thiotepa—hematologic cancer	0.000111	0.000609	CcSEcCtD
Finasteride—Asthenia—Alitretinoin—hematologic cancer	0.000111	0.000608	CcSEcCtD
Finasteride—Rash—Vinorelbine—hematologic cancer	0.000111	0.000608	CcSEcCtD
Finasteride—Dermatitis—Vinorelbine—hematologic cancer	0.00011	0.000607	CcSEcCtD
Finasteride—Headache—Vinorelbine—hematologic cancer	0.00011	0.000604	CcSEcCtD
Finasteride—Influenza—Doxorubicin—hematologic cancer	0.00011	0.000603	CcSEcCtD
Finasteride—Immune system disorder—Prednisone—hematologic cancer	0.00011	0.000602	CcSEcCtD
Finasteride—Hypersensitivity—Vincristine—hematologic cancer	0.000109	0.000601	CcSEcCtD
Finasteride—Asthenia—Ifosfamide—hematologic cancer	0.000109	0.0006	CcSEcCtD
Finasteride—Pruritus—Alitretinoin—hematologic cancer	0.000109	0.000599	CcSEcCtD
Finasteride—Infection—Triamcinolone—hematologic cancer	0.000108	0.000596	CcSEcCtD
Finasteride—Pruritus—Ifosfamide—hematologic cancer	0.000108	0.000592	CcSEcCtD
Finasteride—Dyspnoea—Etoposide—hematologic cancer	0.000107	0.000589	CcSEcCtD
Finasteride—Dizziness—Thalidomide—hematologic cancer	0.000107	0.000589	CcSEcCtD
Finasteride—Somnolence—Etoposide—hematologic cancer	0.000107	0.000588	CcSEcCtD
Finasteride—Hypersensitivity—Irinotecan—hematologic cancer	0.000107	0.000585	CcSEcCtD
Finasteride—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000107	0.000585	CcSEcCtD
Finasteride—Asthenia—Vincristine—hematologic cancer	0.000107	0.000585	CcSEcCtD
Finasteride—Mental disorder—Prednisone—hematologic cancer	0.000106	0.000584	CcSEcCtD
Finasteride—Rash—Thiotepa—hematologic cancer	0.000106	0.00058	CcSEcCtD
Finasteride—Bronchitis—Doxorubicin—hematologic cancer	0.000106	0.00058	CcSEcCtD
Finasteride—Dermatitis—Thiotepa—hematologic cancer	0.000105	0.00058	CcSEcCtD
Finasteride—Headache—Thiotepa—hematologic cancer	0.000105	0.000576	CcSEcCtD
Finasteride—Asthenia—Mitoxantrone—hematologic cancer	0.000104	0.00057	CcSEcCtD
Finasteride—Asthenia—Irinotecan—hematologic cancer	0.000104	0.00057	CcSEcCtD
Finasteride—Dizziness—Carmustine—hematologic cancer	0.000103	0.000565	CcSEcCtD
Finasteride—Pain—Etoposide—hematologic cancer	0.000103	0.000565	CcSEcCtD
Finasteride—Rash—Thalidomide—hematologic cancer	0.000102	0.000561	CcSEcCtD
Finasteride—Dermatitis—Thalidomide—hematologic cancer	0.000102	0.000561	CcSEcCtD
Finasteride—Dizziness—Alitretinoin—hematologic cancer	0.000102	0.00056	CcSEcCtD
Finasteride—Headache—Thalidomide—hematologic cancer	0.000101	0.000558	CcSEcCtD
Finasteride—Pain—Prednisolone—hematologic cancer	0.000101	0.000558	CcSEcCtD
Finasteride—Asthenia—Gemcitabine—hematologic cancer	0.000101	0.000555	CcSEcCtD
Finasteride—Dizziness—Ifosfamide—hematologic cancer	0.000101	0.000553	CcSEcCtD
Finasteride—Pharyngitis—Methotrexate—hematologic cancer	0.000101	0.000553	CcSEcCtD
Finasteride—Pruritus—Gemcitabine—hematologic cancer	9.97e-05	0.000548	CcSEcCtD
Finasteride—Sinusitis—Epirubicin—hematologic cancer	9.92e-05	0.000545	CcSEcCtD
Finasteride—Infection—Betamethasone—hematologic cancer	9.84e-05	0.00054	CcSEcCtD
Finasteride—Infection—Dexamethasone—hematologic cancer	9.84e-05	0.00054	CcSEcCtD
Finasteride—Dizziness—Vincristine—hematologic cancer	9.82e-05	0.00054	CcSEcCtD
Finasteride—Rash—Carmustine—hematologic cancer	9.81e-05	0.000539	CcSEcCtD
Finasteride—Dermatitis—Carmustine—hematologic cancer	9.8e-05	0.000538	CcSEcCtD
Finasteride—Headache—Carmustine—hematologic cancer	9.75e-05	0.000536	CcSEcCtD
Finasteride—Dyspnoea—Triamcinolone—hematologic cancer	9.73e-05	0.000535	CcSEcCtD
Finasteride—Rash—Alitretinoin—hematologic cancer	9.72e-05	0.000534	CcSEcCtD
Finasteride—Dermatitis—Alitretinoin—hematologic cancer	9.71e-05	0.000533	CcSEcCtD
Finasteride—Hypersensitivity—Cisplatin—hematologic cancer	9.67e-05	0.000532	CcSEcCtD
Finasteride—Headache—Alitretinoin—hematologic cancer	9.65e-05	0.000531	CcSEcCtD
Finasteride—Angioedema—Prednisone—hematologic cancer	9.65e-05	0.00053	CcSEcCtD
Finasteride—Rash—Ifosfamide—hematologic cancer	9.6e-05	0.000528	CcSEcCtD
Finasteride—Dermatitis—Ifosfamide—hematologic cancer	9.59e-05	0.000527	CcSEcCtD
Finasteride—Dizziness—Irinotecan—hematologic cancer	9.56e-05	0.000526	CcSEcCtD
Finasteride—Urticaria—Etoposide—hematologic cancer	9.56e-05	0.000525	CcSEcCtD
Finasteride—Rhinitis—Epirubicin—hematologic cancer	9.52e-05	0.000523	CcSEcCtD
Finasteride—Urticaria—Prednisolone—hematologic cancer	9.43e-05	0.000518	CcSEcCtD
Finasteride—Asthenia—Cisplatin—hematologic cancer	9.42e-05	0.000518	CcSEcCtD
Finasteride—Pharyngitis—Epirubicin—hematologic cancer	9.42e-05	0.000518	CcSEcCtD
Finasteride—Rash—Vincristine—hematologic cancer	9.36e-05	0.000515	CcSEcCtD
Finasteride—Dermatitis—Vincristine—hematologic cancer	9.35e-05	0.000514	CcSEcCtD
Finasteride—Oedema peripheral—Epirubicin—hematologic cancer	9.35e-05	0.000514	CcSEcCtD
Finasteride—Pain—Triamcinolone—hematologic cancer	9.33e-05	0.000513	CcSEcCtD
Finasteride—Headache—Vincristine—hematologic cancer	9.3e-05	0.000511	CcSEcCtD
Finasteride—Hypotension—Betamethasone—hematologic cancer	9.25e-05	0.000508	CcSEcCtD
Finasteride—Hypotension—Dexamethasone—hematologic cancer	9.25e-05	0.000508	CcSEcCtD
Finasteride—Sinusitis—Doxorubicin—hematologic cancer	9.18e-05	0.000504	CcSEcCtD
Finasteride—Immune system disorder—Methotrexate—hematologic cancer	9.16e-05	0.000503	CcSEcCtD
Finasteride—Rash—Irinotecan—hematologic cancer	9.12e-05	0.000501	CcSEcCtD
Finasteride—Rash—Mitoxantrone—hematologic cancer	9.12e-05	0.000501	CcSEcCtD
Finasteride—Dermatitis—Mitoxantrone—hematologic cancer	9.11e-05	0.000501	CcSEcCtD
Finasteride—Dermatitis—Irinotecan—hematologic cancer	9.11e-05	0.000501	CcSEcCtD
Finasteride—Headache—Irinotecan—hematologic cancer	9.06e-05	0.000498	CcSEcCtD
Finasteride—Headache—Mitoxantrone—hematologic cancer	9.06e-05	0.000498	CcSEcCtD
Finasteride—Mental disorder—Methotrexate—hematologic cancer	8.89e-05	0.000488	CcSEcCtD
Finasteride—Rash—Gemcitabine—hematologic cancer	8.88e-05	0.000488	CcSEcCtD
Finasteride—Dermatitis—Gemcitabine—hematologic cancer	8.87e-05	0.000488	CcSEcCtD
Finasteride—Hypersensitivity—Etoposide—hematologic cancer	8.86e-05	0.000487	CcSEcCtD
Finasteride—Headache—Gemcitabine—hematologic cancer	8.83e-05	0.000485	CcSEcCtD
Finasteride—Rhinitis—Doxorubicin—hematologic cancer	8.8e-05	0.000484	CcSEcCtD
Finasteride—Hypersensitivity—Prednisolone—hematologic cancer	8.74e-05	0.00048	CcSEcCtD
Finasteride—Pharyngitis—Doxorubicin—hematologic cancer	8.72e-05	0.000479	CcSEcCtD
Finasteride—Urticaria—Triamcinolone—hematologic cancer	8.67e-05	0.000476	CcSEcCtD
Finasteride—Oedema peripheral—Doxorubicin—hematologic cancer	8.65e-05	0.000475	CcSEcCtD
Finasteride—Asthenia—Etoposide—hematologic cancer	8.63e-05	0.000474	CcSEcCtD
Finasteride—Immune system disorder—Epirubicin—hematologic cancer	8.57e-05	0.000471	CcSEcCtD
Finasteride—Infection—Prednisone—hematologic cancer	8.57e-05	0.000471	CcSEcCtD
Finasteride—Pruritus—Etoposide—hematologic cancer	8.51e-05	0.000468	CcSEcCtD
Finasteride—Pain—Dexamethasone—hematologic cancer	8.47e-05	0.000465	CcSEcCtD
Finasteride—Pain—Betamethasone—hematologic cancer	8.47e-05	0.000465	CcSEcCtD
Finasteride—Mental disorder—Epirubicin—hematologic cancer	8.32e-05	0.000457	CcSEcCtD
Finasteride—Rash—Cisplatin—hematologic cancer	8.28e-05	0.000455	CcSEcCtD
Finasteride—Dermatitis—Cisplatin—hematologic cancer	8.27e-05	0.000455	CcSEcCtD
Finasteride—Hypersensitivity—Triamcinolone—hematologic cancer	8.04e-05	0.000442	CcSEcCtD
Finasteride—Dizziness—Etoposide—hematologic cancer	7.95e-05	0.000437	CcSEcCtD
Finasteride—Immune system disorder—Doxorubicin—hematologic cancer	7.93e-05	0.000436	CcSEcCtD
Finasteride—Urticaria—Betamethasone—hematologic cancer	7.86e-05	0.000432	CcSEcCtD
Finasteride—Urticaria—Dexamethasone—hematologic cancer	7.86e-05	0.000432	CcSEcCtD
Finasteride—Dizziness—Prednisolone—hematologic cancer	7.85e-05	0.000431	CcSEcCtD
Finasteride—Asthenia—Triamcinolone—hematologic cancer	7.83e-05	0.00043	CcSEcCtD
Finasteride—Pruritus—Triamcinolone—hematologic cancer	7.72e-05	0.000424	CcSEcCtD
Finasteride—Mental disorder—Doxorubicin—hematologic cancer	7.69e-05	0.000423	CcSEcCtD
Finasteride—Rash—Etoposide—hematologic cancer	7.58e-05	0.000417	CcSEcCtD
Finasteride—Dermatitis—Etoposide—hematologic cancer	7.58e-05	0.000416	CcSEcCtD
Finasteride—Headache—Etoposide—hematologic cancer	7.54e-05	0.000414	CcSEcCtD
Finasteride—Rash—Prednisolone—hematologic cancer	7.48e-05	0.000411	CcSEcCtD
Finasteride—Dermatitis—Prednisolone—hematologic cancer	7.47e-05	0.000411	CcSEcCtD
Finasteride—Headache—Prednisolone—hematologic cancer	7.43e-05	0.000408	CcSEcCtD
Finasteride—Dizziness—Triamcinolone—hematologic cancer	7.22e-05	0.000396	CcSEcCtD
Finasteride—Infection—Methotrexate—hematologic cancer	7.16e-05	0.000393	CcSEcCtD
Finasteride—Asthenia—Dexamethasone—hematologic cancer	7.1e-05	0.00039	CcSEcCtD
Finasteride—Asthenia—Betamethasone—hematologic cancer	7.1e-05	0.00039	CcSEcCtD
Finasteride—Pruritus—Betamethasone—hematologic cancer	7e-05	0.000385	CcSEcCtD
Finasteride—Pruritus—Dexamethasone—hematologic cancer	7e-05	0.000385	CcSEcCtD
Finasteride—Progesterone—ABCB1—hematologic cancer	6.88e-05	0.0178	CrCbGaD
Finasteride—Rash—Triamcinolone—hematologic cancer	6.88e-05	0.000378	CcSEcCtD
Finasteride—Dermatitis—Triamcinolone—hematologic cancer	6.87e-05	0.000378	CcSEcCtD
Finasteride—Urticaria—Prednisone—hematologic cancer	6.85e-05	0.000376	CcSEcCtD
Finasteride—Headache—Triamcinolone—hematologic cancer	6.84e-05	0.000376	CcSEcCtD
Finasteride—Testosterone—ALB—hematologic cancer	6.82e-05	0.0177	CrCbGaD
Finasteride—Hypotension—Methotrexate—hematologic cancer	6.73e-05	0.00037	CcSEcCtD
Finasteride—Infection—Epirubicin—hematologic cancer	6.7e-05	0.000368	CcSEcCtD
Finasteride—Dizziness—Dexamethasone—hematologic cancer	6.55e-05	0.00036	CcSEcCtD
Finasteride—Dizziness—Betamethasone—hematologic cancer	6.55e-05	0.00036	CcSEcCtD
Finasteride—Testosterone—ABCB1—hematologic cancer	6.51e-05	0.0168	CrCbGaD
Finasteride—Dyspnoea—Methotrexate—hematologic cancer	6.42e-05	0.000353	CcSEcCtD
Finasteride—Somnolence—Methotrexate—hematologic cancer	6.41e-05	0.000352	CcSEcCtD
Finasteride—Hypersensitivity—Prednisone—hematologic cancer	6.35e-05	0.000349	CcSEcCtD
Finasteride—Hypotension—Epirubicin—hematologic cancer	6.3e-05	0.000346	CcSEcCtD
Finasteride—Rash—Dexamethasone—hematologic cancer	6.24e-05	0.000343	CcSEcCtD
Finasteride—Rash—Betamethasone—hematologic cancer	6.24e-05	0.000343	CcSEcCtD
Finasteride—Dermatitis—Dexamethasone—hematologic cancer	6.24e-05	0.000343	CcSEcCtD
Finasteride—Dermatitis—Betamethasone—hematologic cancer	6.24e-05	0.000343	CcSEcCtD
Finasteride—Headache—Betamethasone—hematologic cancer	6.2e-05	0.000341	CcSEcCtD
Finasteride—Headache—Dexamethasone—hematologic cancer	6.2e-05	0.000341	CcSEcCtD
Finasteride—Infection—Doxorubicin—hematologic cancer	6.2e-05	0.000341	CcSEcCtD
Finasteride—Asthenia—Prednisone—hematologic cancer	6.19e-05	0.00034	CcSEcCtD
Finasteride—Pain—Methotrexate—hematologic cancer	6.16e-05	0.000339	CcSEcCtD
Finasteride—Pruritus—Prednisone—hematologic cancer	6.1e-05	0.000335	CcSEcCtD
Finasteride—Dyspnoea—Epirubicin—hematologic cancer	6.01e-05	0.00033	CcSEcCtD
Finasteride—Somnolence—Epirubicin—hematologic cancer	5.99e-05	0.000329	CcSEcCtD
Finasteride—Hypotension—Doxorubicin—hematologic cancer	5.83e-05	0.00032	CcSEcCtD
Finasteride—Pain—Epirubicin—hematologic cancer	5.77e-05	0.000317	CcSEcCtD
Finasteride—Urticaria—Methotrexate—hematologic cancer	5.72e-05	0.000315	CcSEcCtD
Finasteride—Dizziness—Prednisone—hematologic cancer	5.7e-05	0.000313	CcSEcCtD
Finasteride—Dyspnoea—Doxorubicin—hematologic cancer	5.56e-05	0.000306	CcSEcCtD
Finasteride—Somnolence—Doxorubicin—hematologic cancer	5.55e-05	0.000305	CcSEcCtD
Finasteride—Rash—Prednisone—hematologic cancer	5.44e-05	0.000299	CcSEcCtD
Finasteride—Dermatitis—Prednisone—hematologic cancer	5.43e-05	0.000298	CcSEcCtD
Finasteride—Headache—Prednisone—hematologic cancer	5.4e-05	0.000297	CcSEcCtD
Finasteride—Urticaria—Epirubicin—hematologic cancer	5.36e-05	0.000294	CcSEcCtD
Finasteride—Pain—Doxorubicin—hematologic cancer	5.34e-05	0.000293	CcSEcCtD
Finasteride—Hypersensitivity—Methotrexate—hematologic cancer	5.31e-05	0.000292	CcSEcCtD
Finasteride—Asthenia—Methotrexate—hematologic cancer	5.17e-05	0.000284	CcSEcCtD
Finasteride—Pruritus—Methotrexate—hematologic cancer	5.1e-05	0.00028	CcSEcCtD
Finasteride—Hypersensitivity—Epirubicin—hematologic cancer	4.97e-05	0.000273	CcSEcCtD
Finasteride—Urticaria—Doxorubicin—hematologic cancer	4.96e-05	0.000272	CcSEcCtD
Finasteride—Asthenia—Epirubicin—hematologic cancer	4.84e-05	0.000266	CcSEcCtD
Finasteride—Pruritus—Epirubicin—hematologic cancer	4.77e-05	0.000262	CcSEcCtD
Finasteride—Dizziness—Methotrexate—hematologic cancer	4.76e-05	0.000262	CcSEcCtD
Finasteride—Hypersensitivity—Doxorubicin—hematologic cancer	4.6e-05	0.000253	CcSEcCtD
Finasteride—Rash—Methotrexate—hematologic cancer	4.54e-05	0.00025	CcSEcCtD
Finasteride—Dermatitis—Methotrexate—hematologic cancer	4.54e-05	0.000249	CcSEcCtD
Finasteride—Headache—Methotrexate—hematologic cancer	4.51e-05	0.000248	CcSEcCtD
Finasteride—AKR1D1—Metabolism—NQO1—hematologic cancer	4.49e-05	0.00124	CbGpPWpGaD
Finasteride—Asthenia—Doxorubicin—hematologic cancer	4.48e-05	0.000246	CcSEcCtD
Finasteride—Dizziness—Epirubicin—hematologic cancer	4.46e-05	0.000245	CcSEcCtD
Finasteride—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	4.43e-05	0.00123	CbGpPWpGaD
Finasteride—Pruritus—Doxorubicin—hematologic cancer	4.41e-05	0.000243	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.39e-05	0.00122	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.26e-05	0.00118	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.26e-05	0.00118	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTM1—hematologic cancer	4.25e-05	0.00118	CbGpPWpGaD
Finasteride—Rash—Epirubicin—hematologic cancer	4.25e-05	0.000234	CcSEcCtD
Finasteride—Dermatitis—Epirubicin—hematologic cancer	4.25e-05	0.000233	CcSEcCtD
Finasteride—AKR1D1—Metabolism—CYCS—hematologic cancer	4.24e-05	0.00118	CbGpPWpGaD
Finasteride—Headache—Epirubicin—hematologic cancer	4.22e-05	0.000232	CcSEcCtD
Finasteride—AKR1D1—Metabolism—HSP90AA1—hematologic cancer	4.22e-05	0.00117	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTP1—hematologic cancer	4.2e-05	0.00116	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTP1—hematologic cancer	4.2e-05	0.00116	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTM1—hematologic cancer	4.19e-05	0.00116	CbGpPWpGaD
Finasteride—Dizziness—Doxorubicin—hematologic cancer	4.13e-05	0.000227	CcSEcCtD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.06e-05	0.00113	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.06e-05	0.00113	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ABCB1—hematologic cancer	3.97e-05	0.0011	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ABCB1—hematologic cancer	3.97e-05	0.0011	CbGpPWpGaD
Finasteride—Rash—Doxorubicin—hematologic cancer	3.93e-05	0.000216	CcSEcCtD
Finasteride—Dermatitis—Doxorubicin—hematologic cancer	3.93e-05	0.000216	CcSEcCtD
Finasteride—Headache—Doxorubicin—hematologic cancer	3.91e-05	0.000215	CcSEcCtD
Finasteride—SRD5A2—Metabolism—GSTM1—hematologic cancer	3.86e-05	0.00107	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—NCOR1—hematologic cancer	3.86e-05	0.00107	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—NCOR1—hematologic cancer	3.86e-05	0.00107	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTM1—hematologic cancer	3.86e-05	0.00107	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.8e-05	0.00105	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTP1—hematologic cancer	3.74e-05	0.00104	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.62e-05	0.001	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—FTCD—hematologic cancer	3.55e-05	0.000984	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GMPS—hematologic cancer	3.55e-05	0.000984	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PHYH—hematologic cancer	3.55e-05	0.000984	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ABCB1—hematologic cancer	3.54e-05	0.000982	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—NCOR1—hematologic cancer	3.44e-05	0.000953	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTM1—hematologic cancer	3.44e-05	0.000953	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—MTHFR—hematologic cancer	3.41e-05	0.000945	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—MTHFR—hematologic cancer	3.41e-05	0.000945	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTP1—hematologic cancer	3.35e-05	0.000928	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTP1—hematologic cancer	3.3e-05	0.000915	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SMPD3—hematologic cancer	3.24e-05	0.0009	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTM1—hematologic cancer	3.07e-05	0.000853	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—MTHFR—hematologic cancer	3.04e-05	0.000843	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTM1—hematologic cancer	3.03e-05	0.000841	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3e-05	0.000833	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3e-05	0.000833	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	2.89e-05	0.000803	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CG—hematologic cancer	2.86e-05	0.000794	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CG—hematologic cancer	2.86e-05	0.000794	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	2.85e-05	0.000792	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ASNS—hematologic cancer	2.84e-05	0.000786	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—B3GAT1—hematologic cancer	2.84e-05	0.000786	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—DCK—hematologic cancer	2.84e-05	0.000786	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	2.72e-05	0.000755	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HDC—hematologic cancer	2.69e-05	0.000745	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	2.68e-05	0.000744	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.68e-05	0.000742	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CREBBP—hematologic cancer	2.66e-05	0.000736	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CREBBP—hematologic cancer	2.66e-05	0.000736	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—FTCD—hematologic cancer	2.56e-05	0.000711	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GMPS—hematologic cancer	2.56e-05	0.000711	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PHYH—hematologic cancer	2.56e-05	0.000711	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CG—hematologic cancer	2.55e-05	0.000708	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CD—hematologic cancer	2.52e-05	0.000698	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CD—hematologic cancer	2.52e-05	0.000698	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ALB—hematologic cancer	2.49e-05	0.000689	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ALB—hematologic cancer	2.49e-05	0.000689	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CDA—hematologic cancer	2.46e-05	0.000682	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	2.4e-05	0.000666	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3R1—hematologic cancer	2.38e-05	0.000659	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3R1—hematologic cancer	2.38e-05	0.000659	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CREBBP—hematologic cancer	2.37e-05	0.000656	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PC—hematologic cancer	2.37e-05	0.000656	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—MTR—hematologic cancer	2.36e-05	0.000654	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SMPD3—hematologic cancer	2.34e-05	0.00065	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GBA—hematologic cancer	2.29e-05	0.000634	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC35B2—hematologic cancer	2.29e-05	0.000634	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CD—hematologic cancer	2.24e-05	0.000622	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	2.24e-05	0.000622	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ALB—hematologic cancer	2.22e-05	0.000614	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CB—hematologic cancer	2.19e-05	0.000609	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CB—hematologic cancer	2.19e-05	0.000609	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3R1—hematologic cancer	2.12e-05	0.000588	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTAP—hematologic cancer	2.09e-05	0.00058	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ASNS—hematologic cancer	2.05e-05	0.000568	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—B3GAT1—hematologic cancer	2.05e-05	0.000568	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—DCK—hematologic cancer	2.05e-05	0.000568	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CB—hematologic cancer	1.96e-05	0.000542	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HDC—hematologic cancer	1.94e-05	0.000539	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTEN—hematologic cancer	1.9e-05	0.000526	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTEN—hematologic cancer	1.9e-05	0.000526	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—FHL2—hematologic cancer	1.86e-05	0.000517	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AGRN—hematologic cancer	1.83e-05	0.000507	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—EP300—hematologic cancer	1.81e-05	0.000501	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—EP300—hematologic cancer	1.81e-05	0.000501	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CDA—hematologic cancer	1.78e-05	0.000493	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—IDH2—hematologic cancer	1.73e-05	0.00048	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HMMR—hematologic cancer	1.73e-05	0.00048	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PC—hematologic cancer	1.71e-05	0.000474	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTEN—hematologic cancer	1.69e-05	0.000469	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC35B2—hematologic cancer	1.65e-05	0.000458	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GBA—hematologic cancer	1.65e-05	0.000458	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ARNTL—hematologic cancer	1.63e-05	0.000452	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—EP300—hematologic cancer	1.61e-05	0.000447	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ACP5—hematologic cancer	1.58e-05	0.000439	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CA9—hematologic cancer	1.58e-05	0.000439	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NCOR2—hematologic cancer	1.56e-05	0.000434	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.56e-05	0.000431	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.53e-05	0.000425	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTAP—hematologic cancer	1.51e-05	0.000419	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—IDH1—hematologic cancer	1.49e-05	0.000413	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCC3—hematologic cancer	1.47e-05	0.000408	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTO1—hematologic cancer	1.47e-05	0.000408	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TXN—hematologic cancer	1.47e-05	0.000408	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SPHK1—hematologic cancer	1.44e-05	0.0004	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.43e-05	0.000396	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.41e-05	0.000391	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—UGT1A1—hematologic cancer	1.38e-05	0.000384	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC22A1—hematologic cancer	1.35e-05	0.000374	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CRABP1—hematologic cancer	1.35e-05	0.000374	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—FHL2—hematologic cancer	1.35e-05	0.000373	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CA—hematologic cancer	1.34e-05	0.000371	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CA—hematologic cancer	1.34e-05	0.000371	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AGRN—hematologic cancer	1.32e-05	0.000366	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALOX5—hematologic cancer	1.31e-05	0.000364	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NUP98—hematologic cancer	1.27e-05	0.000353	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—IDH2—hematologic cancer	1.25e-05	0.000347	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HMMR—hematologic cancer	1.25e-05	0.000347	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ADCY7—hematologic cancer	1.23e-05	0.000342	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NCOA3—hematologic cancer	1.23e-05	0.000342	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NUP214—hematologic cancer	1.23e-05	0.00034	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCG2—hematologic cancer	1.2e-05	0.000333	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTR—hematologic cancer	1.2e-05	0.000333	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CA—hematologic cancer	1.19e-05	0.000331	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GMPS—hematologic cancer	1.19e-05	0.000331	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PHYH—hematologic cancer	1.19e-05	0.000331	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—FTCD—hematologic cancer	1.19e-05	0.000331	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ENO2—hematologic cancer	1.18e-05	0.000326	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.18e-05	0.000326	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CA9—hematologic cancer	1.15e-05	0.000318	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ACP5—hematologic cancer	1.15e-05	0.000318	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTT1—hematologic cancer	1.14e-05	0.000317	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NCOR2—hematologic cancer	1.13e-05	0.000313	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SDC1—hematologic cancer	1.12e-05	0.00031	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—AKT1—hematologic cancer	1.09e-05	0.000303	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—AKT1—hematologic cancer	1.09e-05	0.000303	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.09e-05	0.000302	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—IDH1—hematologic cancer	1.08e-05	0.000299	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TXN—hematologic cancer	1.06e-05	0.000295	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTO1—hematologic cancer	1.06e-05	0.000295	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCC3—hematologic cancer	1.06e-05	0.000295	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SPHK1—hematologic cancer	1.04e-05	0.000289	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1e-05	0.000278	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—AKT1—hematologic cancer	9.74e-06	0.00027	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC22A1—hematologic cancer	9.74e-06	0.00027	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CRABP1—hematologic cancer	9.74e-06	0.00027	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—DCK—hematologic cancer	9.53e-06	0.000264	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.53e-06	0.000264	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ASNS—hematologic cancer	9.53e-06	0.000264	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NQO1—hematologic cancer	9.49e-06	0.000263	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CD44—hematologic cancer	9.49e-06	0.000263	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALOX5—hematologic cancer	9.49e-06	0.000263	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NUP98—hematologic cancer	9.19e-06	0.000255	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HDC—hematologic cancer	9.03e-06	0.00025	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYCS—hematologic cancer	8.98e-06	0.000249	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	8.92e-06	0.000247	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ADCY7—hematologic cancer	8.92e-06	0.000247	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NCOA3—hematologic cancer	8.92e-06	0.000247	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NUP214—hematologic cancer	8.86e-06	0.000246	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCG2—hematologic cancer	8.68e-06	0.000241	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTR—hematologic cancer	8.68e-06	0.000241	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ENO2—hematologic cancer	8.51e-06	0.000236	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CDA—hematologic cancer	8.26e-06	0.000229	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTT1—hematologic cancer	8.25e-06	0.000229	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SDC1—hematologic cancer	8.07e-06	0.000224	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PC—hematologic cancer	7.95e-06	0.000221	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTP1—hematologic cancer	7.92e-06	0.000219	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GBA—hematologic cancer	7.68e-06	0.000213	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.68e-06	0.000213	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCB1—hematologic cancer	7.49e-06	0.000208	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTM1—hematologic cancer	7.27e-06	0.000202	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NCOR1—hematologic cancer	7.27e-06	0.000202	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTAP—hematologic cancer	7.02e-06	0.000195	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CD44—hematologic cancer	6.86e-06	0.00019	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NQO1—hematologic cancer	6.86e-06	0.00019	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYCS—hematologic cancer	6.49e-06	0.00018	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	6.45e-06	0.000179	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTHFR—hematologic cancer	6.43e-06	0.000178	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—FHL2—hematologic cancer	6.26e-06	0.000174	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AGRN—hematologic cancer	6.14e-06	0.00017	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—IDH2—hematologic cancer	5.82e-06	0.000161	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HMMR—hematologic cancer	5.82e-06	0.000161	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTP1—hematologic cancer	5.72e-06	0.000159	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.47e-06	0.000152	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCB1—hematologic cancer	5.42e-06	0.00015	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CG—hematologic cancer	5.4e-06	0.00015	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CA9—hematologic cancer	5.32e-06	0.000148	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ACP5—hematologic cancer	5.32e-06	0.000148	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTM1—hematologic cancer	5.26e-06	0.000146	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NCOR1—hematologic cancer	5.26e-06	0.000146	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.25e-06	0.000146	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CREBBP—hematologic cancer	5.01e-06	0.000139	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—IDH1—hematologic cancer	5.01e-06	0.000139	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TXN—hematologic cancer	4.95e-06	0.000137	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.95e-06	0.000137	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.95e-06	0.000137	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.84e-06	0.000134	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CD—hematologic cancer	4.75e-06	0.000132	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALB—hematologic cancer	4.69e-06	0.00013	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.65e-06	0.000129	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTHFR—hematologic cancer	4.65e-06	0.000129	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.53e-06	0.000126	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.53e-06	0.000126	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3R1—hematologic cancer	4.48e-06	0.000124	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.41e-06	0.000122	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NUP98—hematologic cancer	4.27e-06	0.000118	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.15e-06	0.000115	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.15e-06	0.000115	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CB—hematologic cancer	4.14e-06	0.000115	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NUP214—hematologic cancer	4.12e-06	0.000114	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTR—hematologic cancer	4.03e-06	0.000112	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.03e-06	0.000112	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ENO2—hematologic cancer	3.96e-06	0.00011	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.9e-06	0.000108	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.84e-06	0.000106	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SDC1—hematologic cancer	3.75e-06	0.000104	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.62e-06	0.0001	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTEN—hematologic cancer	3.58e-06	9.92e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.43e-06	9.52e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—EP300—hematologic cancer	3.41e-06	9.46e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALB—hematologic cancer	3.39e-06	9.4e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3R1—hematologic cancer	3.24e-06	8.99e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NQO1—hematologic cancer	3.19e-06	8.84e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CD44—hematologic cancer	3.19e-06	8.84e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYCS—hematologic cancer	3.02e-06	8.37e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3e-06	8.32e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.99e-06	8.3e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.66e-06	7.38e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTEN—hematologic cancer	2.59e-06	7.17e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.52e-06	7e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.52e-06	6.98e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—EP300—hematologic cancer	2.47e-06	6.84e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.44e-06	6.78e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.44e-06	6.78e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.16e-06	5.99e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AKT1—hematologic cancer	2.06e-06	5.72e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.82e-06	5.06e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.82e-06	5.03e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.68e-06	4.67e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.6e-06	4.42e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALB—hematologic cancer	1.58e-06	4.37e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.51e-06	4.18e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AKT1—hematologic cancer	1.49e-06	4.13e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.39e-06	3.86e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTEN—hematologic cancer	1.2e-06	3.33e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—EP300—hematologic cancer	1.15e-06	3.18e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.48e-07	2.35e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AKT1—hematologic cancer	6.93e-07	1.92e-05	CbGpPWpGaD
